Spectrum of Benign Breast Disease; a Critical Review of Therapy: A Single – Center Experience
review
OA: diamond
CC0
Abstract
Background: A benign breast condition is one that is not cancer. These conditions often go away on their own or are easily treated. Because a few benign breast conditions can increase your risk of getting cancer in the future, you may need to have follow-up tests or exams with your benign breast disease comprises a large spectrum of disease which ranges from mastalgia, nipple discharge to discrete lump. Medical management with Danazol, bromocriptine, primrose oil and Vitamin E capsules has importance along with surgical intervention in few cases.
Materials and Methods: One hundred and one (n=101) patients with mastalgia, nipple discharge and breast lump were treated with medical or surgical management. Post treatment all patients were followed up for symptomatic relief.
Results: Majority of the patients (n=64) presented with mastalgia. Rest of the patients presented with nipple discharge and discrete lump. Most patients (n=75) were treated with Danazol, Linoleic Acid or Vitamin E. 85% patients were satisfied with the treatment administered to them.
Conclusion: Benign breast disease is a diverse spectrum with miscellaneous symptoms. Benign breast diseases are common in female patients and fibroadenoma is the commonest of them all. Triple assessment gave a firm diagnosis and it eliminates unnecessary anxiety in the patients about breast cancer or any other serious illness. Medical management is mainstay with indication of surgery in few cases.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (51)
- Cyclical mastopathy: A critical review of therapy via openalex
- doi:10.1007/978-3-642-76054-9_2 via openalex
- doi:10.1097/00006534-198604000-00059 via openalex
- doi:10.1111/j.1365-2559.1989.tb03044.x via openalex
- doi:10.1016/s1056-8727(03)00034-5 via openalex
- doi:10.1053/ctrv.2001.0234 via openalex
- doi:10.1177/030089168507100213 via openalex
- doi:10.1056/nejm198501173120303 via openalex
- doi:10.1097/00125480-199501000-00003 via openalex
- W69237303 via openalex
- W87402208 via openalex
- W111200779 via openalex
- W1425560223 via openalex
- W1478003326 via openalex
- doi:10.1016/j.ejso.2004.08.004 via openalex
- doi:10.1111/j.1075-122x.2004.21373.x via openalex
- doi:10.1093/aje/155.2.103 via openalex
- W2418254650 via openalex
- W2433434199 via openalex
- W2789067045 via openalex
- W6603002905 via openalex
- W6604514868 via openalex
- W6628456306 via openalex
- W6642728757 via openalex
- W6645176590 via openalex
- W6663073998 via openalex
- W6673341149 via openalex
- W6799344923 via openalex
- W6844823988 via openalex
- doi:10.1053/j.semdp.2003.10.011 via openalex
- doi:10.1016/s1043-321x(06)80327-9 via openalex
- doi:10.1136/jcp.56.10.721 via openalex
- doi:10.1016/s0002-9378(97)70392-2 via openalex
- doi:10.1093/oxfordjournals.aje.a112594 via openalex
- doi:10.1136/jmg.24.12.778 via openalex
- doi:10.1186/bcr623 via openalex
- doi:10.1016/s0960-9776(03)00123-1 via openalex
- doi:10.1016/j.breast.2004.04.011 via openalex
- doi:10.1007/s00268-002-6563-6 via openalex
- doi:10.1053/j.semdp.2003.10.010 via openalex
- doi:10.1002/1097-0142(19871201)60:11<2751::aid-cncr2820601127>3.0.co;2-m via openalex
- doi:10.1016/j.ejso.2005.04.004 via openalex
- doi:10.1016/0046-8177(89)90063-4 via openalex
- doi:10.1016/j.breast.2004.04.008 via openalex
- doi:10.1111/j.1600-0560.1999.tb01827.x via openalex
- doi:10.1002/path.1711460102 via openalex
- doi:10.1046/j.1524-4741.2001.07611.x via openalex
- doi:10.1007/s00268-003-6806-1 via openalex
- doi:10.1007/s00404-003-0561-2 via openalex
- doi:10.1097/00006254-200207000-00022 via openalex
- doi:10.1016/s1072-7515(01)00959-0 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T04:09:40.449411+00:00
License: CC0
· commercial use OK